We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Drug Induced Liver Injury

    Hepatotoxicity is toxic damage to the liver that includes the nature of the hepatotoxic agent, the type and mechanism of liver injury, the...
    Nora V. Bergasa in Clinical Cases in Hepatology
    Chapter 2022
  2. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update

    Drug-induced liver injury (DILI) is an important adverse drug reaction that can lead to acute liver failure or even death in severe cases. Currently,...

    Yimin Mao, Shiwu Ma, ... **aoyun Li in Hepatology International
    Article 24 February 2024
  3. Drug-induced liver injury due to tofacitinib: a case report

    Background

    Drug-induced liver injury is an acute or chronic liver damage in response to drugs, herbals, and any chemical compound.

    Case presentation ...
    Masoud Mardani, Jafar Mohammadshahi, ... Roghayeh Teimourpour in Journal of Medical Case Reports
    Article Open access 18 March 2023
  4. The mitochondrial fusion protein OPA1 is dispensable in the liver and its absence induces mitohormesis to protect liver from drug-induced injury

    Mitochondria are critical for metabolic homeostasis of the liver, and their dysfunction is a major cause of liver diseases. Optic atrophy 1 (OPA1) is...

    Hakjoo Lee, Tae ** Lee, ... Yisang Yoon in Nature Communications
    Article Open access 23 October 2023
  5. Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

    The elderly demographic is the fastest-growing segment of the worldā€™s population and is projected to exceed 1.5 billion people by 2050. With...

    Eric B. Cohen, Meenal Patwardhan, ... M Isabel Lucena in Drug Safety
    Article Open access 13 January 2024
  6. Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids

    Preclinical models that can accurately predict the toxicity and efficacy of candidate drugs to human liver tissue are in urgent need. Human liver...

    **aoshan Wu, Dacheng Jiang, ... Qiurong Ding in Cell Regeneration
    Article Open access 03 March 2023
  7. Identification of MRI features associated with injury type, severity, and prognosis in drug-induced liver injury

    Objectives

    To identify magnetic resonance imaging (MRI) features associated with injury type, severity, and liver transplantation (LT)/liver-related...

    Ting Wu, Dawei Yang, ... Hong Ma in European Radiology
    Article 18 August 2022
  8. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study

    Background

    The objective of this research was to create and validate an interpretable prediction model for drug-induced liver injury (DILI) during...

    Yue **ao, Yanfei Chen, ... Tianchi Yang in BMC Medical Research Methodology
    Article Open access 20 April 2024
  9. A brief overview of drug-induced liver damage

    Drug-induced liver injury (DILI) is a prevalent disorder that can be led on by almost all drug types. The majority of benign DILI cases become better...

    Soumyadip Roy, Zalak Shah, G. S. Chakraborthy in The Egyptian Journal of Internal Medicine
    Article Open access 30 May 2024
  10. Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases

    Purpose

    Selective androgen receptor modulators (SARMs) have demonstrated agonist activity on the androgen receptor in various tissues, stimulating...

    Natalia Leciejewska, Karol Jędrejko, ... Andrzej Pokrywka in European Journal of Clinical Pharmacology
    Article Open access 07 December 2023
  11. InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism

    Safety is one of the important factors constraining the distribution of clinical drugs on the market. Drug-induced liver injury (DILI) is the leading...

    Soyeon Lee, Sunyong Yoo in Journal of Cheminformatics
    Article Open access 03 January 2024
  12. Unraveling the treatment effects of huanglian jiedu decoction on drug-induced liver injury based on network pharmacology, molecular docking and experimental validation

    Huanglian Jiedu Decoction (HJD) is a well-known Traditional Chinese Medicine formula that has been used for liver protection in thousands of years....

    Yaochen **e, Shuchen Gong, ... Qinjie Weng in BMC Complementary Medicine and Therapies
    Article Open access 07 June 2024
  13. The immunological mechanisms and therapeutic potential in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity

    Acute liver failure caused by drug overdose is a significant clinical problem in developed countries. Acetaminophen (APAP), a widely used analgesic...

    Qianhui Li, Feng Chen, Fei Wang in Cell & Bioscience
    Article Open access 22 November 2022
  14. Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury

    Background

    Anti-tuberculosis drug-induced liver injury (AT-DILI) is one of the most common side effects in TB patients during treatment. The prime...

    Heikrujam Nilkanta Meitei, Anupama Pandey, Reena Haobam in Molecular Biology Reports
    Article 23 December 2022
  15. Artificial Intelligence-Based Techniques to Assess Drug Toxicity in Drug-Induced Liver Injury (DILI) Disease

    Drug-induced liver injury (DILI) is difficult to detect, and a rare condition which is responsible for drug removal from the market. DILI poses a...
    Chapter 2022
  16. A system that delivers an antioxidant to mitochondria for the treatment of drug-induced liver injury

    Mitochondria, a major source of reactive oxygen species (ROS), are intimately involved in the response to oxidative stress in the body. The...

    Mitsue Hibino, Masatoshi Maeki, ... Yuma Yamada in Scientific Reports
    Article Open access 10 May 2023
  17. Transcriptional profiling of drug-induced liver injury biomarkers: association of hepatic Srebf1/PparĪ± signaling and crosstalk of thrombin, alcohol dehydrogenase, MDR and DNA damage regulators

    Cell stress transcribing genes provide a diverse platform of molecular mediators that vary in response to toxicity. Common drug-induced liver injury...

    Bayan Y. Ghanim, Mohammad Ahmad, ... Nidal A. Qinna in Molecular and Cellular Biochemistry
    Article 30 December 2022
  18. Cholangiocyte organoids to study drug-induced injury

    Background

    Drug induced bile duct injury is a frequently observed clinical problem leading to a wide range of pathological features. During the past...

    Zhenguo Wang, Chen **ng, ... Rosalinde Masereeuw in Stem Cell Research & Therapy
    Article Open access 13 March 2024
  19. Unraveling the mechanisms underlying drug-induced cholestatic liver injury: identifying key genes using machine learning techniques on human in vitro data sets

    Drug-induced intrahepatic cholestasis (DIC) is a main type of hepatic toxicity that is challenging to predict in early drug development stages....

    Jian Jiang, Jonas van Ertvelde, ... Mathieu Vinken in Archives of Toxicology
    Article Open access 21 August 2023
  20. Drug-Induced Nephrotoxicity and Use of Biomarkers

    Nephrotoxicity has been defined as renal injury that is caused due to direct or indirect exposure, mostly to drugs and other exogenous industrial or...
    Radhika Sharma, Reshma Sinha, ... Seema Rani in Biomarkers in Toxicology
    Reference work entry 2023
Did you find what you were looking for? Share feedback.